Accelerated Approval Of Hiberix To Help Sustain Adequate Vaccine Supply

The U.S. Food and Drug Administration approved Hiberix, a Haemophilus influenzae Type b (Hib) vaccine, as a booster dose for children 15 months through 4 years old. Hiberix is manufactured by GlaxoSmithKline, with U.S. headquarters in Research Triangle Park, N.C. and Philadelphia.

More: continued here

Filed under: Immune System / Vaccines on August 23rd, 2009